The precise magic of CRISPR.

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• MCF7 breast cancer cells contain multiple copies (4-5) of the FOXA1 gene on chromosome 14.
• Editing genes present in multiple copies in polyploid cells is a significant challenge in genome engineering.

Purpose of the Study:

• To develop a proof-of-principle method for correcting all copies of a specific gene in a polyploid cancer cell line.
• To establish a robust genome editing strategy for polyploid cancer cells.

Main Methods:

• Utilized a classical CRISPR/Cas9 system with sgRNA and Cas9 expressed from a single vector.
• Incorporated a puromycin resistance cassette for selection of successfully edited cells.
• Employed a non-linearized plasmid as a targeting template for efficient gene modification, introducing a specific mutation (K295Q) in the FOXA1 gene.

Main Results:

• Successfully corrected all copies of the FOXA1 gene in MCF7 cells.
• Demonstrated the efficiency of the CRISPR/Cas9 system with a single vector and puromycin selection.
• Identified non-linearized plasmids as the most efficient targeting template for this strategy.

Conclusions:

• The developed CRISPR/Cas9 strategy is effective for genome editing of multi-copy genes in polyploid cancer cells.
• This technique provides a foundation for creating isogenic cancer models to study gene function and polymorphisms.
• Applications include optimizing cancer treatment protocols and advancing personalized therapy through the study of cancer progression and metastasis.